BURLINGTON, N.C.--(BUSINESS WIRE)-- LabCorp (NYSE: LH), a leading global life sciences company that is deeply integrated in guiding patient care, today announced that it is dedicating the first hour ...
Labcorp OnDemand enables convenient testing with the NASHnext® test, within a physician-directed care pathway to support identification of ...
BURLINGTON, N.C.--(BUSINESS WIRE)--Labcorp (NYSE: LH), a leading global life sciences company, today announced that it has closed its acquisition of Personal Genome Diagnostics Inc. (PGDx), a leader ...
GlobalData on MSN
Labcorp announces partnership for colorectal cancer trials
The trial will assess if direct outreach by healthcare providers increases cascade genetic testing among first-degree ...
BURLINGTON, N.C.--(BUSINESS WIRE)--Labcorp (NYSE: LH), a global life sciences company, is now offering observed self-collection for COVID-19 PCR testing in more than 500 of its patient service centers ...
Innovative GFAP blood biomarker test expands Labcorp's portfolio of tests for diseases including Alzheimer's disease, multiple sclerosis, glioblastoma and brain injuries BURLINGTON, N.C., April 15, ...
First FDA-cleared rapid fentanyl test of its kind made in the United States designed to help emergency department and hospital teams act quickly when every second counts Fentanyl Urine Visual Test is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results